EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Testosterone and the Heart

Travis Goodale, Archana Sadhu, Steven Petak, Richard Robbins

Methodist DeBakey Cardiovascular Journal · 01.04.2017 · 13 (2) · 68

DOI: 10.14797/mdcj-13-2-68 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Methodist DeBakey Cardiovascular Journal, online erschienen am 01.04.2017. Verfasst von Travis Goodale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist Hospital, Houston, Texas. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testosterone (T) has a number of important effects on the cardiovascular system. In men, T levels begin to decrease after age 40, and this decrease has been associated with an increase in all-cause mortality and cardiovascular (CV) risk. Low T levels in men may increase their risk of developing coronary artery disease (CAD), metabolic syndrome, and type 2 diabetes. Reduced T levels in men with congestive heart failure (CHF) portends a poor prognosis and is associated with increased mortality. Studies have reported a reduced CV risk with higher endogenous T concentration, improvement of known CV risk factors with T therapy, and reduced mortality in T-deficient men who underwent T replacement therapy versus untreated men. Testosterone replacement therapy (TRT) has been shown to improve myocardial ischemia in men with CAD, improve exercise capacity in patients with CHF, and improve serum glucose levels, HbA1c, and insulin resistance in men with diabetes and prediabetes. There are no large long-term, placebo-controlled, randomized clinical trials to provide definitive conclusions about TRT and CV risk. However, there currently is no credible evidence that T therapy increases CV risk and substantial evidence that it does not. In fact, existing data suggests that T therapy may offer CV benefits to men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCardiovascular SystemFemaleHormone Replacement TherapyHumansMaleRecovery of FunctionRisk FactorsTestosteroneTreatment Outcome

Stichwörter der Autor:innen

androgendihydrotestosteronetestosteronetestosterone deficiencytestosterone replacement therapy

Substanzen

Testosterone

Autor:innen und Institutionen

  • Houston Methodist Hospital, Houston, Texas.

Zitieren

APA

Goodale, T., Sadhu, A., Petak, S., & Robbins, R. (2017). Testosterone and the Heart. Methodist DeBakey Cardiovascular Journal, 13(2), 68. https://doi.org/10.14797/mdcj-13-2-68

Vancouver

Goodale T, Sadhu A, Petak S, Robbins R. Testosterone and the Heart. Methodist DeBakey Cardiovascular Journal. 2017;13(2):68. doi:10.14797/mdcj-13-2-68

BibTeX
@article{Goodale2017,
  author = {Goodale, Travis and Sadhu, Archana and Petak, Steven and Robbins, Richard},
  title = {Testosterone and the Heart},
  journal = {Methodist DeBakey Cardiovascular Journal},
  year = {2017},
  volume = {13},
  number = {2},
  pages = {68},
  doi = {10.14797/mdcj-13-2-68}
}
Kostenlos starten →